comparemela.com

Latest Breaking News On - குறுகிய குடல் நோய்க்குறி - Page 2 : comparemela.com

9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020

9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020

9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Zealand Pharma: on Track for Potential First Product Launch and Establishing Commercial Operations in the United States

Zealand Pharma: on Track for Potential First Product Launch and Establishing Commercial Operations in the United States
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Researchers develop a better solution to treat short bowel syndrome

Researchers develop a better solution to treat short bowel syndrome Short Bowel Syndrome (SBS) is a medical disorder caused by a lack of a fully functional small intestine. Whether caused as a birth defect or because part of the small intestine was removed during surgery, SBS is a rare disorder, affecting approximately 13 000 people in the European Union. If left untreated, the condition can prevent the gut from performing its nutritional function. Unfortunately, there is no cure for SBS, and current treatment options have low survival rates and can cause serious side-effects – especially for children. That is why researchers with the EU-funded INTENS project are committed to developing a better solution.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.